See the DrugPatentWatch profile for jardiance
Does Jardiance Cause Yeast Infections?
Yes, Jardiance (empagliflozin), an SGLT2 inhibitor for type 2 diabetes, increases the risk of yeast infections, particularly genital ones like candidiasis. This happens because the drug causes more glucose to be excreted in urine, creating a favorable environment for yeast growth in the genital area.[1][2]
How Common Are Yeast Infections with Jardiance?
Clinical trials showed genital yeast infections in 5.4-6.4% of women and 1.5-1.6% of men taking Jardiance, compared to 1.5% and 0.4% on placebo. Rates are higher than with placebo but similar to other SGLT2 inhibitors.[1][3] Real-world reports from patients often highlight recurrent infections, especially in the first few months of use.[2]
Why Does It Happen More in Women?
Women face higher risk due to anatomy and hormonal factors that make genital yeast infections more common overall. Studies report up to 10-12% incidence in women on SGLT2 inhibitors versus 2-3% in men.[3][4] Keeping blood sugar controlled and practicing good hygiene reduces but doesn't eliminate the risk.
What Do Patients Report Happening?
Common symptoms include itching, burning, redness, and thick white discharge in women; men may get balanitis (redness, soreness under foreskin). Infections can recur if not treated promptly with antifungals like fluconazole or topical creams.[2][5] Some users switch drugs if infections persist.
How to Prevent or Manage Them
- Drink plenty of water to dilute urine glucose.
- Maintain hygiene: urinate after sex, wear cotton underwear, avoid douches.
- Treat early with over-the-counter antifungals; see a doctor for severe cases.
- Risk drops after the first 3-6 months as the body adjusts.[2][4]
Compared to Other Diabetes Drugs
Jardiance has similar yeast infection rates to Invokana (canagliflozin) and Farxiga (dapagliflozin), all SGLT2 inhibitors. Metformin or DPP-4 inhibitors like Januvia carry much lower risk (under 1-2%).[3][6]
Any Long-Term Risks?
Repeated infections can lead to skin irritation or rarely more serious issues like Fournier's gangrene (a black-box warning for SGLT2 class), but yeast infections themselves are usually mild and treatable.[1][5]
[1]: FDA Jardiance Label
[2]: Mayo Clinic - Empagliflozin Side Effects
[3]: NEJM - EMPA-REG OUTCOME Trial
[4]: Diabetes Care - SGLT2 Genital Infections Review
[5]: Drugs.com - Jardiance Side Effects
[6]: DrugPatentWatch.com - Empagliflozin Patent Status